Private Equity
ComForCare, a home care franchisor, has named Steven Greenbaum as its new CEO. Greenbaum is the former CEO of PostNet. ComForCare is backed by The Riverside Company.
3 min read · 03 January 2018
Waltham, Massachusetts and New York City-based Syntimmune Inc, a biotech company, has named Dr. Jean-Paul Kress as president and CEO. Kress succeeds Dr. David de Graaf who has stepped down from his CEO position and resigned from the company's board of directors. Prior to joining Syntimmune, Kress worked at Biogen Inc where he served as executive vice president and president, international and head of global therapeutic operations. Syntimmune's backers include by Apple Tree Partners, Partners Innovation Fund, FMB Research and AFB Fund.
4 min read · 03 January 2018
NovaQuest Capital Management has agreed to acquire drug developer Viamet Pharmaceuticals. No financial terms were disclosed. Patrick Jordan, a partner at NovaQuest Capital, will become Viamet's interim CEO while Dr. Robert Schotzinger will remain as president and CEO of the Viamet group of companies.
5 min read · 03 January 2018
WestView Capital Partners has made a "significant" investment in Concord, California-based Jopari Solutions Inc, a healthcare information technology company. No financial terms were disclosed. In addition to the funding, Kevin Twomey, a senior associate at WestView, will join Jopari's board of directors.
3 min read · 03 January 2018
Maravai LifeSciences, a portfolio company of GTCR, has acquired Glen Research Corp. Financial terms weren’t announced. Glen Research, of Sterling, Virginia, provides reagents used in the synthesis of DNA and RNA.
2 min read · 03 January 2018
4 min read · 02 January 2018
Birner Dental Management Services Inc, which acquires and manages manages dental practice networks in Colorado, New Mexico, and Arizona, has raised $5 million in a private placement from Palm Investors. Also, a portion of the transaction's proceeds were used to recapitalize its existing debt, which include paying back about $1.5 million of a loan from Guaranty Bank and Trust Company. In conjunction with the private placement, Birner has named Palm Investors' Joshua S. Horowitz and Bradley Tirpak to its board of directors.
5 min read · 29 December 2017
4 min read · 28 December 2017
Altus Capital Partners has completed its tender offer for all of the outstanding shares of MGC Diagnostics Corporation at $11.03 per share. At the close of the market on December 28, 2017, MGC is expected to stop trading on the NASDAQ. Headquartered in St. Paul, Minnesota, MGC is a provider of cardiorespiratory health solutions.
3 min read · 28 December 2017
3 min read · 27 December 2017
